[Post-transfusional non-A non-B hepatitis. Evaluation of SGPT screening in blood donors].

Abstract

The incidence of non-A, non-B hepatitis is 10% of post-transfusion hepatitis (PTH), and more than 30% of this occurrence could be prevented with SGPT screening. We have been studying from 1984 this surrogate test in order to prevent non-A, non-B post-transfusion hepatitis. Reported data suggest this screening in all blood donors.